Skip to main content

Relias Media has upgraded our site!

Please bear with us as we work through some issues in order to provide you with a better experience.

Thank you for your patience.

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

A Cochrane review questions the value of osletamivir and zanamivir in the treatment of influenza virus infections – but the CDC and IDSA disagree.

Neuraminidase Inhibitor Therapy of Influenza Virus Infections — Yes or No?